NEW YORK (GenomeWeb News) – GE Healthcare and Geron jointly announced today that they will collaborate on developing and selling human embryonic stem cell-based assays for drug discovery, development, and toxicity screening.
Registering provides access to this and other free content.
Already have an account?Login Now.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.